Articles in section Licensing
| << Joint Venture | 540 articles | Mergers & Acquisitions >> |
| << Previous | Pages 1 2 3 4 5 .. 54 | Next >> |
-
Pfizer and 3SBio Forge US$6 B Oncology Alliance to Advance Bispecific Antibody Therapy
-
Novo Nordisk Signs US$2.2B Licensing Pact with Septerna for Obesity
-
Repertoire Signs US$765 M Partnership with Genentech to Advance T Cell Therapies for Autoimmune Diseases
-
GSK Signs US$2.7B+ Licensing Pact with ABL Bio for Neurodegenerative Diseases
-
Novo Nordisk Partners with The United Laboratories for US$2 B Cardiometabolic Drug Development
-
Roche Pays Zealand Pharma US$1.65 B Upfront for Obesity Drug Petrelintide
-
AbbVie Enters Obesity Space Through US$2.2 B Licensing Pact with Gubra
-
Biogen Gains Rights to Stoke Therapeutics’ Zorevunersen for the Treatment of Dravet Syndrome
-
GSK Signs US$1 B+ Partnerships with Duality Biologics and Rgenta Therapeutics
-
Novartis Pays US$150 M Upfront for Monte Rosa’s Molecular Glue Degrader
RSS